Molecular Mechanisms Mediating Antiangiogenic Action of the Urokinase Receptor-Derived Peptide UPARANT in Human Retinal Endothelial Cells
Author(s) -
Carla Motta,
Gabriella Lupo,
Dario Rusciano,
Melania Olivieri,
Liliana Lista,
Mario De Rosa,
Vincenzo Pavone,
Carmelina Daniela Anfuso
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-19909
Subject(s) - urokinase receptor , angiogenesis , vascular endothelial growth factor , microbiology and biotechnology , mapk/erk pathway , protein kinase b , receptor , signal transduction , endothelial stem cell , vascular endothelial growth factor a , biology , cancer research , chemistry , in vitro , biochemistry , vegf receptors
To investigate the molecular mechanisms of the antiangiogenic activity of UPARANT, an antagonist of the urokinase-type plasminogen activator receptor (uPAR), on primary human retinal endothelial cells (HREC) as a model of in vitro angiogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom